Systematic Review Of The Economic Value Of Diarrheal Vaccines

ASU Author/Contributor (non-ASU co-authors, if there are any, appear on document)
Richard Rheingans Ph.D., Department Chair (Creator)
Appalachian State University (ASU )
Web Site:

Abstract: Diarrheal disease is a leading cause of child mortality in low-income settings and morbidity across a range of settings. A growing number of studies have addressed the economic value of new and emerging vaccines to reduce this threat. We conducted a systematic review to assess the economic value of diarrheal vaccines targeting a range of pathogens in different settings. The majority of studies focused on the economic value of rotavirus vaccines in different settings,with most of these concluding that vaccination would provide significant economic benefits across a range of vaccine prices. There is also evidence of the economic benefits of cholera vaccines in specific contexts. For other potentialdiarrheal vaccines data are limited and often hypothetical. Across all target pathogens and contexts, the evidence of economic value focuses the short-term health and economic gains. Additional information is needed on the broadersocial and long-term economic value of diarrhea vaccines.

Additional Information

Rheingans R, Amaya M, Anderson J, Chakraborty P, Atem J. 2014. Systematic Review of the Economic Value of Diarrheal Vaccines, Human Vaccines and Immunotherateutics, 10(6):1582-94. ISSN 2164-5515. Version of record available at:
Language: English
Date: 2014

Email this document to